Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Small Molecule Libraries | 3 | 2020 | 720 | 0.250 |
Why?
|
| Serpins | 1 | 2020 | 247 | 0.170 |
Why?
|
| Uridine | 1 | 2018 | 146 | 0.150 |
Why?
|
| Phenyl Ethers | 1 | 2017 | 58 | 0.150 |
Why?
|
| Glycolysis | 2 | 2011 | 827 | 0.140 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2020 | 1369 | 0.140 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2017 | 295 | 0.140 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2010 | 507 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2023 | 3760 | 0.130 |
Why?
|
| Carbon Isotopes | 4 | 2010 | 467 | 0.130 |
Why?
|
| Gastropoda | 1 | 2015 | 8 | 0.130 |
Why?
|
| Mollusca | 1 | 2015 | 40 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2023 | 1058 | 0.130 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 436 | 0.130 |
Why?
|
| Nitrogen Isotopes | 2 | 2010 | 84 | 0.110 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.100 |
Why?
|
| Phosphoglycerate Mutase | 1 | 2010 | 11 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2015 | 730 | 0.090 |
Why?
|
| bcl-X Protein | 1 | 2011 | 411 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 1903 | 0.080 |
Why?
|
| Pyruvate Kinase | 1 | 2010 | 189 | 0.080 |
Why?
|
| Glucose | 2 | 2011 | 4397 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2019 | 1905 | 0.080 |
Why?
|
| Hydrogen | 1 | 2007 | 164 | 0.070 |
Why?
|
| Proteins | 2 | 2011 | 6103 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2020 | 4445 | 0.060 |
Why?
|
| Netropsin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7880 | 0.060 |
Why?
|
| Carbon | 1 | 2007 | 687 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10481 | 0.050 |
Why?
|
| Peptides | 1 | 2015 | 4409 | 0.050 |
Why?
|
| Biliverdine | 1 | 2002 | 29 | 0.050 |
Why?
|
| Metallothionein | 1 | 2002 | 59 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2018 | 3752 | 0.050 |
Why?
|
| Neoplasms | 3 | 2020 | 21683 | 0.050 |
Why?
|
| Cell Survival | 1 | 2011 | 5882 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2942 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2010 | 2025 | 0.050 |
Why?
|
| Models, Molecular | 3 | 2018 | 5456 | 0.040 |
Why?
|
| Granzymes | 1 | 2020 | 271 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2002 | 895 | 0.040 |
Why?
|
| Fluorescence Polarization | 1 | 2018 | 132 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2023 | 3129 | 0.040 |
Why?
|
| Niacin | 1 | 2018 | 116 | 0.040 |
Why?
|
| Apoptosis | 3 | 2020 | 9727 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 16689 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 35421 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 1355 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2019 | 1899 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2015 | 134 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2015 | 354 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 1012 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 2015 | 193 | 0.030 |
Why?
|
| Binding Sites | 2 | 2018 | 6114 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2015 | 407 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 2751 | 0.030 |
Why?
|
| Candidiasis | 1 | 2015 | 366 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 944 | 0.030 |
Why?
|
| Caspase 2 | 1 | 2011 | 27 | 0.030 |
Why?
|
| Candida albicans | 1 | 2015 | 394 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 1246 | 0.030 |
Why?
|
| Phospholipids | 1 | 2015 | 784 | 0.020 |
Why?
|
| Glyceric Acids | 1 | 2010 | 17 | 0.020 |
Why?
|
| Phosphoenolpyruvate | 1 | 2010 | 16 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 1294 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 135 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 1434 | 0.020 |
Why?
|
| DNA | 1 | 2004 | 7301 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2011 | 743 | 0.020 |
Why?
|
| Histidine | 1 | 2010 | 313 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 2010 | 200 | 0.020 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2010 | 137 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 1877 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.020 |
Why?
|
| Acetylation | 1 | 2011 | 1085 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3586 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 809 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2010 | 595 | 0.020 |
Why?
|
| Animals | 7 | 2020 | 168757 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2007 | 138 | 0.020 |
Why?
|
| Cell Line | 2 | 2011 | 15997 | 0.020 |
Why?
|
| Entropy | 1 | 2007 | 209 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2007 | 447 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6386 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 7181 | 0.020 |
Why?
|
| Ligands | 2 | 2004 | 3282 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2219 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2010 | 1726 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 1701 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 3748 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
| Granulocytes | 1 | 2007 | 548 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 3128 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9386 | 0.020 |
Why?
|
| Methanol | 1 | 2005 | 85 | 0.020 |
Why?
|
| Mice | 4 | 2015 | 81183 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 249 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2004 | 293 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 1990 | 0.010 |
Why?
|
| Urea | 1 | 2005 | 450 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 21827 | 0.010 |
Why?
|
| Microscopy, Scanning Tunneling | 1 | 2002 | 1 | 0.010 |
Why?
|
| Kinetics | 1 | 2010 | 6473 | 0.010 |
Why?
|
| Chlorine | 1 | 2002 | 50 | 0.010 |
Why?
|
| Buffers | 1 | 2002 | 147 | 0.010 |
Why?
|
| Melanoma | 1 | 2020 | 5510 | 0.010 |
Why?
|
| Solutions | 1 | 2002 | 426 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2004 | 572 | 0.010 |
Why?
|
| Cadmium | 1 | 2002 | 212 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6622 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 1157 | 0.010 |
Why?
|
| Gadolinium | 1 | 2005 | 952 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2002 | 626 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 1460 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2004 | 2011 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2010 | 8436 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 1572 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2002 | 957 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 1539 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 1060 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 3848 | 0.010 |
Why?
|
| Mitosis | 1 | 2002 | 1208 | 0.010 |
Why?
|
| Protons | 1 | 2002 | 1127 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 4894 | 0.010 |
Why?
|
| Research Design | 1 | 2010 | 5987 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20822 | 0.010 |
Why?
|
| Female | 3 | 2020 | 380194 | 0.010 |
Why?
|
| Humans | 5 | 2018 | 744343 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 12797 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 19229 | 0.010 |
Why?
|
| Software | 1 | 2005 | 4443 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 11124 | 0.000 |
Why?
|
| Time Factors | 1 | 2002 | 40075 | 0.000 |
Why?
|
| Male | 1 | 2010 | 350118 | 0.000 |
Why?
|
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_